Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Angiodynamics Inc (ANGO)

144 + Investors. Track Smart Money conviction in ANGO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -19
Streak
1Q ▼
Buyers last Q
45%

Smart Money Signals — ANGO

Based on 146 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ANGO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 88% of 3.0Y peak

88% of all-time peak
146 funds currently hold this stock — 88% of the 3.0-year high of 165 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 5% fewer funds vs a year ago

fund count last 6Q
8 fewer hedge funds hold ANGO compared to a year ago (-5% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 45% buying

75 buying93 selling
Last quarter: 93 funds reduced or exited vs 75 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-16 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 18 → 22 → 35 → 19. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

62% of holders stayed for 2+ years

■ 62% conviction (2yr+) ■ 20% medium ■ 18% new
91 out of 146 hedge funds have held ANGO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📈

Growing discovery — still being found

37 → 18 → 22 → 35 → 19 new funds/Q
New funds entering each quarter: 18 → 22 → 35 → 19. A growing number of institutions are discovering ANGO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 70% veterans vs 19% newcomers

■ 70% veterans ■ 11% 1-2yr ■ 19% new
Entry-cohort mix of 151 holders: 106 (70%) are 2+ year veterans, 16 entered 1–2 years ago, and 29 (19%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
38 of 146 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.2
out of 10
Low Exit Risk
Exit risk score 3.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ANGO

In 2026 Q1, 75 hedge funds were net buyers of ANGO (19 opened a new position, 56 added to an existing one), while 93 reduced or exited (55 trimmed, 38 sold completely) — a 45% buyer ratio, indicating roughly balanced activity. 22% of total institutional value in ANGO is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -19 funds (more exits than new entries). Total institutional holders: 146.

Hedge Fund Ownership: ANGO

How many hedge funds hold ANGO — quarterly history vs. share price
Quarterly hedge fund ownership of ANGO vs. share price

Market Analysis: ANGO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ANGO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Angiodynamics Inc (ANGO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ANGO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
ANGO
+6.9%
XLV
+1.6%

ANGO outperformed XLV by +5.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
ANGO
+12.8%
XLV
+2.7%

Since the filing became public, ANGO outperformed XLV by +10.1% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 3 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
2.5
/ 10
conviction
Hedge Fund Positioning: ANGO
144 + Investors

Track Smart Money conviction in ANGO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 144 165 -12.73%
13F Shares 39M 39M -0.12%
Total Value $434M $497M -12.65%
New Positions 17 35 -18
Increased Positions 55 57 -2
Closed Positions 38 15 +23
Reduced Positions 53 50 +3
Total Calls 4 3 33.33%
Total Puts 1 0 100%
PUT/CALL Ratio 0.25 0.0 Bullish

Statistics: ANGO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

144 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ANGO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ANGO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Broadfin Holdings LLC 100.00% 2,069,333 $23.5M
2 Weber Capital Management LLC /Adv 15.60% 1,373,149 $15.6M
3 Bastion Asset Management Inc. 4.30% 1,313,002 $14.1M
4 Pier Capital, LLC 1.49% 796,696 $9.1M
5 Manatuck Hill Partners, LLC 1.46% 475,000 $5.4M
6 Systematic Financial Management LP 0.64% 2,453,701 $27.9M
7 Phocas Financial Corp. 0.55% 308,146 $3.5M
8 White Pine Capital LLC 0.40% 124,615 $1.4M
9 Armistice Capital, LLC 0.38% 1,869,000 $21.3M
10 Paradigm Capital Management Inc/Ny 0.31% 718,200 $8.2M
11 Divisadero Street Capital Management, LP 0.27% 562,153 $6.4M
12 Globeflex Capital L P 0.18% 104,155 $1.2M
13 Segall Bryant & Hamill, LLC 0.17% 969,313 $10.7M
14 Royce & Associates LP 0.17% 1,528,951 $17.4M
15 Moody National Bank Trust Division 0.05% 47,927 $545K
16 Kennedy Capital Management LLC 0.05% 196,813 $2.2M
17 Point72 Asset Management, L.P. 0.05% 3,181,829 $36.2M
18 Moore Capital Management, LP 0.05% 195,503 $2.2M
19 StoneX Group Inc. 0.04% 64,109 $729K
20 Inceptionr LLC 0.03% 10,131 $115K
21 AlphaQuest LLC 0.02% 33,677 $432K
22 Gallagher Fiduciary Advisors, LLC 0.02% 45,832 $521K
23 Y-Intercept (Hong Kong) Ltd 0.02% 80,391 $914K
24 State of Wyoming 0.02% 11,199 $127K
25 Renaissance Technologies LLC 0.01% 803,283 $9.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Angiodynamics Inc (ANGO)

What does the Smart Money Trend signal show for ANGO?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ANGO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ANGO?

More sellers than buyers — 45% buying: Last quarter: 93 funds reduced or exited vs 75 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for ANGO holders?

Strong quality — 22% AUM from major funds: 38 of 146 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ANGO?

62% of holders stayed for 2+ years: 91 out of 146 hedge funds have held ANGO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Angiodynamics Inc (ANGO) following the 2026 Q1 hedge fund 13F filings?

As of today, ANGO has moved +12.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +2.7% for the XLV sector ETF — an outperformance of +10.1%. Since the quarter end (March 31, 2026), ANGO has gained +6.9% vs +1.6% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →